Long COVID and the Immune System: Why It Can Be Both Overactive and Underactive

Reading time: approximately 8 minutes | Last updated: October 2026 | Brain fog friendly

ong COVID immune system dysfunction is not simply a weak immune system or an overactive one. Research suggests that some immune pathways can remain unusually active months after infection, while others show changes in their ability to coordinate a normal response. Studies have identified persistent inflammation, altered T-cell and B-cell populations, autoantibodies and possible reactivation of dormant viruses such as Epstein-Barr virus (EBV).

These abnormalities are not found in everyone, and scientists are still working out which are causes, consequences or markers of Long COVID. But the emerging picture is fascinating: an immune system can be working overtime without necessarily working well.

5 Key Facts About Long COVID Immune Dysfunction

  1. Immune activation can persist long after infection. Researchers have identified altered inflammatory signals and immune-cell populations months after COVID in some patients.
  2. An overactive immune response doesn’t mean every immune defence is functioning normally. Changes involving T cells, B cells and dendritic cells suggest that different parts of the immune system may become poorly coordinated.
  3. Autoimmunity may contribute to symptoms. Autoantibodies have been identified in some people with Long COVID, although their role in causing symptoms remains uncertain.
  4. Dormant viruses may become active again. EBV and other herpesviruses are being investigated as possible contributors to persistent symptoms and immune disruption.
  5. There is no single immune pattern shared by everyone. Immune abnormalities may overlap with vascular, neurological, autonomic and metabolic problems, helping explain why Long COVID looks so different between patients.

When Your Immune System Seems to Be Doing Two Opposite Things

Have you ever wondered how your body can seem to react to everything, yet struggle to recover from something as ordinary as a cold?

Perhaps a minor infection leaves you exhausted for weeks. Or you suddenly develop sensitivities to foods, fragrances or medications that never bothered you before. Meanwhile, your blood tests come back normal, and nobody can explain why your body still feels as though it’s fighting something.

One of the most interesting discoveries in Long COVID research is that the immune system doesn’t simply become overactive or underactive. Different parts can behave in completely different ways at the same time.

It’s a bit like driving with one foot on the accelerator and the other on the brake. The engine is working hard, but the car isn’t running efficiently.

That’s the contradiction scientists are beginning to uncover. Some immune cells remain unusually active, producing inflammatory signals, while others show signs of altered function or poor coordination. And because the immune system communicates with almost every organ, the consequences may extend far beyond fighting infections.

This could help explain why Long COVID looks so different from one person to another. Some people experience persistent inflammatory or hypersensitivity-type symptoms, while others are more affected by neurological, vascular, autonomic or metabolic problems.

Researchers are increasingly investigating different biological patterns, or Long COVID phenotypes, rather than expecting every patient to have the same underlying problem.

So what exactly is happening inside the immune system?

How the Long COVID Immune System Becomes Hyperactive

Normally, the immune system responds to an infection, deals with the threat and gradually settles down. In some people with Long COVID, however, parts of that response appear to remain unusually active long after the original infection.

Researchers have identified changes in inflammatory signalling, cytokines, chemokines and immune-cell populations. These are the chemical messages and specialised cells that help the body recognise threats and coordinate its response.

A 2022 Nature Immunology study led by Chansavath Phetsouphanh identified persistent immune abnormalities up to eight months after infection, including changes in innate immune cells and inflammatory signalling.

Then, in 2023, a landmark Nature study led by Jon Klein identified several distinctive immune features in people with Long COVID. These included increased non-conventional monocytes, altered B-cell populations and T cells displaying markers associated with exhaustion.

Monocytes are immune cells involved in recognising threats and coordinating inflammatory responses. When their activity remains altered, researchers suspect they may contribute to persistent immune signalling.

But what does that actually mean for someone living with Long COVID?

Imagine your body’s emergency response system never quite receiving the message that the immediate danger has passed. The infection may be over, but parts of the immune response are still behaving as though something needs attention.

Think of inflammation as a smoke alarm. It is supposed to ring when there is danger, then switch off when the smoke clears. But imagine the alarm continuing long after the fire has gone out. The alarm isn’t necessarily protecting the house anymore; it has become part of the disturbance.

Researchers suspect something similar may be happening in certain forms of Long COVID.

Persistent immune activation may contribute to symptoms such as fatigue, pain and the general feeling of being unwell. But these symptoms are likely to involve several overlapping biological mechanisms, rather than inflammation alone.

And here’s another frustration patients will recognise: routine inflammatory blood tests can remain normal, even when specialised research identifies differences in immune markers.

This is one reason why normal test results do not necessarily explain away Long COVID symptoms.

The immune system may be behaving differently without producing the abnormalities that standard blood tests are designed to detect.

The Other Side: When Parts of the Immune Response Underperform

Here is where the science becomes even more interesting.

The same 2023 Nature study that identified signs of persistent immune activation also found reduced populations of conventional type 1 dendritic cells and central memory CD4 T cells in its Long COVID cohort.

Dendritic cells help recognise threats and present information to other immune cells. Memory T cells contribute to longer-term immune responses, helping the body respond to threats it has encountered before.

Researchers have also reported T-cell populations displaying markers associated with exhaustion. In immunology, this describes changes that can occur when immune cells experience prolonged stimulation. However, finding exhaustion markers does not automatically prove that a person’s immune defences have failed.

A 2024 Nature Immunology study led by Kailin Yin and colleagues added another important piece of the puzzle. Researchers identified systemic inflammation, altered T-cell populations and less coordinated responses between T cells and B cells in people with Long COVID.

At first glance, this sounds impossible. How can an immune system be too active and not active enough at the same time?

Because the immune system isn’t one single switch. It’s a network of different cells and pathways, each with its own job. Some may remain unusually active, while others struggle to communicate or respond in the usual way.

Imagine an emergency department where alarms are sounding everywhere, but the teams responsible for different emergencies are no longer communicating properly. There is plenty of activity, yet the response becomes less coordinated.

That is one way to understand what researchers mean by immune dysregulation.

Some people with Long COVID report catching infections more frequently or taking longer to recover from ordinary illnesses. These experiences deserve attention, although research has not established that the immune-cell abnormalities identified in Long COVID directly cause increased infection susceptibility in everyone.

So perhaps the question isn’t whether your immune system is too strong or too weak. What if it’s doing too much of the wrong thing while struggling with some of the jobs it should be doing?

That is the contradiction researchers are trying to understand.

Autoimmunity: When the Immune System Targets the Body Itself

For many people, the word autoimmunity sounds frightening because it is associated with conditions such as lupus, rheumatoid arthritis and multiple sclerosis.

But autoimmunity isn’t always as straightforward as having a diagnosed autoimmune disease.

The immune system normally produces antibodies that recognise foreign threats. Sometimes, however, it produces antibodies that recognise the body’s own molecules. These are called autoantibodies.

Researchers have identified different autoantibodies in some people following COVID, including antibodies directed against proteins involved in immune signalling and other biological functions.

One possible explanation is molecular mimicry. Parts of a virus may resemble human proteins closely enough that an immune response against the virus also recognises components of the body.

It’s rather like a security system trained to recognise an intruder, only to discover that some ordinary residents resemble the original suspect.

Of particular interest are autoantibodies involving adrenergic and muscarinic receptors. These receptors participate in regulating heart rate, blood pressure and autonomic functions.

Researchers are investigating whether such antibodies might contribute to symptoms including palpitations, dizziness and orthostatic intolerance, which can overlap with POTS and other forms of autonomic dysfunction.

However, an important distinction remains: finding an autoantibody does not prove that it is causing someone’s symptoms. Autoantibodies can also occur after infections, in other illnesses and sometimes in people without a diagnosed autoimmune disease.

COVID may also trigger or reveal an underlying autoimmune condition in some individuals. Studies have reported associations between SARS-CoV-2 infection and subsequent autoimmune diagnoses, although the relationship varies by condition and study.

For a closer look at the evidence, read Can COVID Trigger Autoimmune Conditions?.

The bigger question is whether particular autoantibodies actually interfere with normal biological functions—and whether removing or blocking them could improve symptoms.

That is what makes this research so important. If autoimmune mechanisms are driving illness in a particular subgroup, they could eventually become targets for more personalised treatment.

Reactivated Latent Viruses: Old Passengers Woken Up

Most of us carry viruses that have been quietly living in our bodies for years. We may have completely forgotten about the original infection, but some viruses never entirely leave.

Instead, they remain dormant, usually kept under control by the immune system.

One of the emerging ideas in Long COVID research is that immune disruption following SARS-CoV-2 infection may allow some of these old passengers to become active again.

The best-studied example is Epstein-Barr virus (EBV), which causes glandular fever and remains latent in most adults after infection.

A major 2022 study published in Cell, led by Yapeng Su, followed 309 people with COVID and identified several early factors associated with later post-COVID symptoms. These included EBV viraemia, SARS-CoV-2 RNA in the blood, certain autoantibodies and pre-existing type 2 diabetes.

This was an important finding because it suggested that what happens during the initial infection—including changes involving other viruses—may influence what happens months later.

The 2023 Nature immune-profiling study also found higher antibody levels against EBV and varicella-zoster virus in its Long COVID group.

But antibody results are not always straightforward. Higher antibody levels can reflect previous immune exposure and do not necessarily prove that a virus is actively replicating.

And EBV may not be the only old passenger waking up. Researchers are also investigating human herpesvirus 6 (HHV-6), another virus that can remain dormant after infection.

The possibility is intriguing: perhaps the immune system is not only dealing with the aftermath of SARS-CoV-2 but also responding to other viruses that have become active again.

Yet there is an important question scientists still cannot fully answer.

Is EBV reactivation adding fuel to Long COVID, or is it simply revealing how unsettled the immune system has become?

It could potentially be both in some patients. In others, EBV may play little or no role.

This is why the research matters, but also why a positive EBV antibody test cannot automatically explain someone’s Long COVID symptoms.

If you’ve experienced recurring sore throats, swollen lymph nodes or fatigue reminiscent of glandular fever, our separate guide explores the link between EBV reactivation and Long COVID symptoms.

Mast Cell Activation: Why Your Body May Suddenly React to Everything

One of the stranger experiences reported by some people with Long COVID is developing sensitivities that never existed before.

A food you’ve eaten for years suddenly causes discomfort. A fragrance becomes unbearable. You experience flushing, itching, hives or digestive symptoms without understanding why.

Could the immune system be involved?

Researchers are investigating whether mast cells, immune cells involved in allergic and inflammatory responses, contribute to these symptoms in certain patients.

Mast cells are found throughout the body, particularly in tissues exposed to the outside world, such as the skin, respiratory tract and digestive system. They release histamine and other substances that help coordinate inflammatory responses.

One hypothesis is that immune disruption changes the threshold at which mast cells respond to certain triggers. In other words, something that previously passed unnoticed may now provoke a stronger reaction.

But this is an area where the science is still developing.

Some studies and clinical observations suggest mast-cell involvement, while others have not found consistent elevations in markers of mast-cell activation.

And although symptoms such as flushing, itching, gastrointestinal disturbance and new sensitivities can resemble mast cell activation syndrome (MCAS), having these symptoms does not automatically mean someone has MCAS.

Allergies, medication reactions, digestive disorders and autonomic dysfunction can produce overlapping symptoms.

For patients, the important point is that new sensitivities deserve investigation rather than dismissal. Researchers still need to establish how frequently mast-cell pathways are involved in Long COVID and whether treatments targeting them improve the underlying condition.

How It All Fits Together: One Problem or Several Interconnected Ones?

Here is perhaps the most important question of all.

What if these aren’t completely separate problems?

The immune system communicates constantly with blood vessels, nerves, hormones, the gut and the tissues responsible for producing energy.

Persistent immune activation could influence T-cell function. Altered immune surveillance might make viral reactivation more likely. Viral antigens or reactivated viruses could provide further immune stimulation, while autoimmune and inflammatory pathways might overlap with autonomic or vascular dysfunction.

Researchers are also investigating the gut microbiome and its relationship with the immune system and brain.

The gut contains a large immune network, and changes in its microbial communities may influence inflammation, immune signalling and communication between different organs.

Meanwhile, research into blood-vessel dysfunction in Long COVID raises further questions about how inflammation and vascular abnormalities might interact.

It’s tempting to imagine one domino falling and knocking down everything else. But the evidence isn’t yet strong enough to establish one universal chain of events.

Different mechanisms may interact in some patients while remaining relatively independent in others.

This may be why two people can develop Long COVID after the same virus yet experience completely different symptoms. One struggles mainly with brain fog and cognitive exhaustion. Another develops palpitations and dizziness. Someone else experiences digestive problems, new sensitivities or severe post-exertional malaise.

It may also help explain why symptoms change over time—and why treatments targeting only one proposed mechanism have not produced a reliable solution for everyone.

Perhaps Long COVID isn’t one biological problem with many symptoms, but several overlapping problems that can influence one another.

Understanding those differences may be essential for developing treatments that work for the right patients.

Quick Answers

Is Long COVID an autoimmune disease?

Not as one universally defined autoimmune disease. Autoantibodies and other autoimmune features have been identified in some patients, but Long COVID includes several biological mechanisms. Some people may develop a separate autoimmune condition after COVID, while others have immune abnormalities without meeting the criteria for an autoimmune disease.

Why do I seem to catch more infections since developing Long COVID?

Some people report more frequent infections or unusually prolonged recovery after ordinary illnesses. Research has identified altered immune-cell populations in certain Long COVID groups, but it has not established that these findings explain increased infection susceptibility in everyone. Recurrent or unusually severe infections deserve clinical assessment rather than automatically being attributed to Long COVID.

What is EBV reactivation, and could it be part of my Long COVID?

EBV remains dormant in most adults after the initial infection. Some studies have identified markers associated with EBV reactivation in people who develop Long COVID. Researchers are investigating whether this contributes to symptoms or reflects wider immune dysfunction. EBV antibody results require careful interpretation because past infection is extremely common.

What is MCAS, and how do I know if it is part of my Long COVID?

Mast cell activation syndrome involves episodes of excessive mast-cell mediator release that can affect multiple organ systems. Symptoms may include flushing, hives, digestive disturbances and other hypersensitivity reactions. Some Long COVID symptoms overlap with MCAS, but diagnosis requires appropriate clinical assessment and, where indicated, supporting laboratory evidence.

Why might autoantibodies contribute to POTS symptoms?

Researchers have identified antibodies targeting receptors involved in autonomic regulation in some patients with POTS and Long COVID. These findings have led to hypotheses about autoimmune contributions to heart-rate and blood-pressure abnormalities. However, their causal role is not yet established, and such antibodies are not currently a routine diagnostic test for post-COVID POTS.

Can the immune system recover after Long COVID?

Some longitudinal research suggests that certain immune abnormalities can diminish over time. A 2024 Nature Communications study found improvement in several measures of immune activation over 24 months, although some differences persisted. This does not mean every patient’s symptoms resolve or that immune recovery follows the same timeline for everyone.

Should I have immune testing done?

Testing should be guided by symptoms and clinical findings. A GP may consider blood counts, inflammatory markers or immunoglobulin testing when appropriate, particularly if there are recurrent infections or signs of another immune disorder. Specialised immune profiling used in research is not yet a routine diagnostic test for Long COVID.

Is there a treatment for immune dysfunction in Long COVID?

There is currently no established treatment that reliably reverses Long COVID immune dysfunction. Researchers are investigating immune-modulating therapies, approaches targeting inflammation and treatments aimed at possible viral persistence. Some may prove useful for particular patient groups, but trial evidence is needed before they can be recommended routinely.

The Bigger Picture: An Immune System That Has Lost Its Balance

One of the hardest things about Long COVID is how unpredictable it can feel. You may experience inflammation-like symptoms one week, overwhelming fatigue the next, and then a new sensitivity or an unexpected setback after an infection.

The emerging research suggests that, in some patients, different parts of the immune system may remain activated, altered or poorly coordinated long after the initial infection.

That doesn’t yet tell us how to fix the problem. But it changes the question researchers are asking.

Instead of simply asking whether the immune system is too strong or too weak, scientists are beginning to ask which parts are behaving differently, what is keeping them that way, and whether restoring better coordination could help people recover.

That may prove to be one of the most important directions in Long COVID research.


Related Articles From LongCovidJourney

  1. Long COVID and Autoimmunity: Can COVID Trigger Autoimmune Disease?
  2. Why Do I Feel Like I Have Glandular Fever After COVID?
  3. Why Did I Suddenly Develop New Food Intolerances After COVID?
  4. Long COVID and the Gut: What the Microbiome Research Really Shows
  5. Long COVID Normal Tests: Why You Feel Unwell Even When Results Are Normal
  6. Long COVID Phenotypes Explained: Understanding the Different Types of Long COVID
  7. Immunotherapies and Monoclonal Antibodies in Long COVID: Evidence, Trials and Clinical Uncertainty

Scientific References

  1. Klein J, et al. (2023). Distinguishing features of long COVID identified through immune profiling. Nature, 623, 139–148. Read study
  2. Phetsouphanh C, et al. (2022). Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nature Immunology, 23, 210–216. Read study
  3. Münch and colleagues / Roan research group (2024). Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nature Immunology, 25, 218–225. Read study
  4. Su Y, et al. (2022). Multiple early factors anticipate post-acute COVID-19 sequelae. Cell, 185, 881–895.e20. Read study
  5. Altmann DM, et al. (2023). The immunology of long COVID. Nature Reviews Immunology, 23, 618–634. Read review
  6. Phetsouphanh and colleagues (2024). Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection. Nature Communications. Read study
  7. Research published in Nature Communications (2024). Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19. Nature Communications, 15, Article 8941. Read study